[Skip to Content]
[Skip to Content Landing]
November 1949


Author Affiliations

NEW HAVEN, CONN.; Medical Corps, Army of the United States
Formerly Major, Medical Corps, Army of the United States.

Arch Surg. 1949;59(5):1122-1134. doi:10.1001/archsurg.1949.01240041132012

THE TREATMENT of venous thrombosis has been revolutionized in the past two decades by the use of anticoagulant drugs (heparin sodium and dicumarol®) and by ligation of the involved veins (usually the femoral vein). Ligation of the inferior vena cava has been carried out infrequently. It is evident that in the past few years interest in, and a study of, this formerly rare procedure have been greatly accelerated. Doubtless, the motivating force behind this increased interest is the usefulness of ligation as an additional weapon in our armamentarium to forestall the sudden catastrophe of embolic disease. The use of this measure is not advocated as a replacement for anticoagulant therapy or for ligation of the femoral vein, but rather as an additional method for use when these procedures may be inadequate; we feel that ligation of the vena cava is indicated much more frequently than it is used. After a

First Page Preview View Large
First page PDF preview
First page PDF preview